Clinical trials
When the world's leading medical journals get together to warn that commercial pressures are threatening the objectivity of clinical trials, the pharmaceuticals industry should listen carefully. In a
Related Content
- HIV drug resistance: brief report 2024
- Guidance for evaluation of novel applications for COVID-19
- Flooded by the torrent: the COVID-19 drug pipeline
- A trial of Lopinavir–Ritonavir in adults hospitalized with severe Covid-19
- Order of the Delhi High Court regarding permission to avail “Human Embryonic Stem Cell Therapy”, 15/04/2019
- ISCR: New rules for drugs, clinical trials to protect rights, safety of patients